Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia
NCT03342261
·
clinicaltrials.gov ↗
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C, Chronic
Mixed Cryoglobulinemia
Interventions
DRUG:
DAA treatment
Sponsor
Hospices Civils de Lyon